Botulinum toxin (BoNT) is an effective and safe therapy for the symptomatic treatment of
several neurological disturbances. An important line of research has provided numerous …

The medical treatment of Parkinson's disease (PD) is symptomatic both in terms of motor
and nonmotor aspects. The nonmotor symptoms therapy should be taken into account as …

Parkinson's disease (PD) is a terminal, debilitating neurodegenerative disorder typically
affecting individuals over 60. It is associated with various conditions that drastically affect the …

Objective To evaluate the efficacy and safety of botulinum toxin (BTX) for motor dysfunction
in Parkinson's disease (PD). Design Systematic review and meta-analysis. Data sources …

Botulinum toxin (BoNT) therapy is frequently employed in the treatment of Parkinson's
disease (PD) symptoms. It can effectively ameliorate the symptoms of cervical dystonia …

Over the past 30 years, Botulinum toxin (BoNT) has emerged as an effective and safe
therapeutic tool for a number of neurological conditions, including dystonia. To date, the …

Botulinum toxin is one of the most potent neurotoxins, but when injected into an overactive
muscle, it can transiently alleviate an involuntary movement, such as dystonia. The primary …

Many studies have shown that botulinum toxin (BoNT) can be an option to treat motor and
non-motor symptoms in Parkinson's disease (PD) and parkinsonian syndromes. The …

Botulinum neurotoxin (BoNT) is a useful therapeutic option to treat dystonic manifestations.
Data on its efficiency on dystonia associated with Parkinson's disease (PD) or atypical …

Parkinson's disease (PD) is one of the most frequent neurodegenerative disorders. Its main
pathophysiological characteristic is the loss of dopaminergic neurons in the substantia nigra …